Top Health Care Reform Stories
FDA chief open to rethinking orphan-drug incentives
By Sarah Jane Tribble, Kaiser Health NewsIn an interview last week, the FDAs Scott Gottlieb said the Orphan Drug Act of 1983 has provided an enormous amount of public health value over the years, but the market has changed.